9,790
Total Claims
$2.2M
Drug Cost
768
Beneficiaries
$2,899
Cost/Patient
Peer Comparison vs. 9,082 Pulmonary Disease providers
-44%
Cost per patient vs peers
$2,899 vs $5,138 avg
-55%
Brand preference vs peers
27.4% vs 61.4% avg
Brand vs Generic
73% generic
Brand: 2,667 claims · $2.0M
Generic: 7,072 claims · $257K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Fluticasone/Umeclidin/Vilanter | 222 | $201K |
| Tiotropium Bromide | 208 | $197K |
| Dapagliflozin Propanediol | 152 | $179K |
| Empagliflozin | 127 | $168K |
| Apixaban | 181 | $157K |
| Budesonide/Formoterol Fumarate | 222 | $109K |
| Umeclidinium Bromide | 194 | $99K |
| Budesonide/Glycopyr/Formoterol | 125 | $93K |
| Pirfenidone | 18 | $81K |
| Rivaroxaban | 60 | $71K |
| Tiotropium Bromide | 80 | $54K |
| Fluticasone Propion/Salmeterol | 104 | $53K |
| Semaglutide | 21 | $39K |
| Dulaglutide | 28 | $39K |
| Fluticasone/Vilanterol | 72 | $37K |
Prescribing Profile
Patient Profile
75
Avg Age
57%
Female
1.56
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About